Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alopecia
ETG Mark I receives CE medical mark
March 24th, 2005
Current Technology Corp. (CRTCF.OB), developer of ETG (ElectroTrichoGenesis), a patented electrotherapeutic device that provides, according to Current, a clinically proven medical treatment for alopecia, or hair loss, announced that it has received the CE medical mark for its ETG Mark I device. During the last quarter of 2004 KEMA Quality BV, Arnhem, the Netherlands, conducted audits and examinations in accordance with the applied conformity assessment procedures and has determined that the quality system maintained by Current Technology and its ETG Mark 1 electric pulse stimulator for the treatment of hair loss comply with the requirements of European...
Source: Women's Health Weekly (2005-03-24)
|
